摘要
在2019年12月,湖北省武汉市发现一种新型冠状病毒,世界卫生组织(WHO)于2020年2月11日将其命名为"2019-nCoV".目前对新型冠状病毒肺炎(简称新冠肺炎)认识不足,其临床表现多样化,造成治疗困难.现就1例治愈的新冠肺炎患者的临床表现、实验室检查结果特别是中性粒细胞/淋巴细胞比值(NLR)、超敏C-反应蛋白(hs-CRP)和CT影像动态演变结果进行分析,发现NLR和hs-CRP在疾病转变的过程中对临床治疗有指导作用.
In December 2019,a new coronavirus was discovered in Wuhan,Hubei Province.The World Health Organization(WHO)named it 2019 novel coronavirus(2019-nCoV).Due to insufficient understanding of corona virus disease 2019(COVID-19),the clinical manifestations are diverse,making treatment difficult.The author analyzed the clinical manifestations,laboratory test results of a patient with COVID-19,especially the neutrophil/lymphocyte ratio(NLR),high-sensitivity C-reactive protein(hs-CRP),and the dynamic evolution results of CT images,and found that NLR and hs-CRP has a guiding role in clinical treatment during the course of disease transformation.
作者
吕建森
徐勋
徐洪铭
徐世文
吴立峰
黄冠成
Lyu Jiansen;Xu Xun;Xu Hongming;Xu Shiwen;WuLifeng;Huang Guancheng(Department of Critical Care MediciNEUT,Yuyao People's Hospital,Yuyao 315400,Zhejiang,China;Department of Infectious Diseases,Yuyao People's Hospital,Yuyao 315400,Zhejiang,China;Department of Emergency,Yuyao People's Hospital,Yuyao 315400,Zhejiang,China;Department of Respiratory Diseases,Yuyao People's Hospital,Yuyao 315400,Zhejiang,China)
出处
《中国中西医结合急救杂志》
CAS
CSCD
北大核心
2020年第1期50-52,共3页
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
